Annual Cash & Cash Equivalents
$4.59 M
-$15.46 M-77.09%
December 31, 2023
Summary
- As of March 13, 2025, NRXPW annual cash & cash equivalents is $4.59 million, with the most recent change of -$15.46 million (-77.09%) on December 31, 2023.
- During the last 3 years, NRXPW annual cash & cash equivalents has risen by +$2.74 million (+147.18%).
- NRXPW annual cash & cash equivalents is now -83.35% below its all-time high of $27.61 million, reached on December 31, 2021.
Performance
NRXPW Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.65 M
-$252.00 K-13.28%
September 30, 2024
Summary
- As of March 13, 2025, NRXPW quarterly cash and cash equivalents is $1.65 million, with the most recent change of -$252.00 thousand (-13.28%) on September 30, 2024.
- Over the past year, NRXPW quarterly cash and cash equivalents has stayed the same.
- NRXPW quarterly cash and cash equivalents is now -95.91% below its all-time high of $40.20 million, reached on March 31, 2022.
Performance
NRXPW Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NRXPW Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -77.1% | 0.0% |
3 y3 years | +147.2% | -93.3% |
5 y5 years | +10000.0% | -93.3% |
NRXPW Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -83.3% | at low | -95.9% | +24.8% |
5 y | 5-year | -83.3% | >+9999.0% | -95.9% | >+9999.0% |
alltime | all time | -83.3% | >+9999.0% | -95.9% | >+9999.0% |
NRx Pharmaceuticals Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.65 M(-13.3%) |
Jun 2024 | - | $1.90 M(+43.9%) |
Mar 2024 | - | $1.32 M(-71.3%) |
Dec 2023 | $4.59 M(-77.1%) | $4.59 M(-48.4%) |
Sep 2023 | - | $8.90 M(-63.7%) |
Dec 2022 | $20.05 M(-27.4%) | - |
Jun 2022 | - | $24.55 M(-38.9%) |
Mar 2022 | - | $40.20 M(+45.6%) |
Dec 2021 | $27.61 M | $27.61 M(-29.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $38.88 M(+190.5%) |
Jun 2021 | - | $13.39 M(>+9900.0%) |
Dec 2020 | $1.86 M(>+9900.0%) | $0.47(+1075.0%) |
Sep 2020 | - | $0.04(-99.4%) |
Jun 2020 | - | $7.00(-100.0%) |
Mar 2020 | - | $80.77 K(>+9900.0%) |
Dec 2019 | $6.00 | $6.00(-100.0%) |
Sep 2019 | - | $194.28 K(>+9900.0%) |
Jun 2019 | - | $1394.00(-23.3%) |
Mar 2019 | - | $1818.00 |
FAQ
- What is NRx Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is NRx Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is NRx Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of NRXPW is $4.59 M
What is the all time high annual cash & cash equivalents for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual cash & cash equivalents is $27.61 M
What is NRx Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, NRXPW annual cash & cash equivalents has changed by -$15.46 M (-77.09%)
What is NRx Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NRXPW is $1.65 M
What is the all time high quarterly cash and cash equivalents for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly cash and cash equivalents is $40.20 M
What is NRx Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, NRXPW quarterly cash and cash equivalents has changed by $0.00 (0.00%)